These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18431247)

  • 21. Molecular characterization of occult hepatitis B cases in Greek blood donors.
    Katsoulidou A; Paraskevis D; Magiorkinis E; Moschidis Z; Haida C; Hatzitheodorou E; Varaklioti A; Karafoulidou A; Hatzitaki M; Kavallierou L; Mouzaki A; Andrioti E; Veneti C; Kaperoni A; Zervou E; Politis C; Hatzakis A
    J Med Virol; 2009 May; 81(5):815-25. PubMed ID: 19319945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study.
    Ikeda K; Kobayashi M; Someya T; Saitoh S; Hosaka T; Akuta N; Suzuki F; Suzuki Y; Arase Y; Kumada H
    J Viral Hepat; 2009 Jun; 16(6):437-43. PubMed ID: 19226331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.
    Lukhwareni A; Burnett RJ; Selabe SG; Mzileni MO; Mphahlele MJ
    J Med Virol; 2009 Mar; 81(3):406-12. PubMed ID: 19152393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occult hepatitis B infection in blood donors.
    Reesink HW; Engelfriet CP; Henn G; Mayr WR; Delage G; Bernier F; Krusius T; Assal A; Gallian P; Corbi C; Morel P; David B; De Micco P; Murokawa H; Yugi H; Hino S; Tadokoro K; Flesland O; Brojer E; Letowska M; Olim G; Nascimento F; Gonçalves H; Castro L; Morais M; Stezinar SL; Alvarez M; Sauleda S; González R; Niederhauser C; Stolz M; Allain JP; Owusu-Ofori S; Eglin R; Stramer S; Busch M; Strong DM; Epstein J; Biswas R
    Vox Sang; 2008 Feb; 94(2):153-66. PubMed ID: 18205672
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis B viral infection in South west Saudi Arabia.
    Arya SC; Agarwal N; Ayoola AE
    Saudi Med J; 2004 Mar; 25(3):390; author reply 390. PubMed ID: 15048188
    [No Abstract]   [Full Text] [Related]  

  • 27. HBV-DNA in hemodialysis patients infected by HCV.
    Arababadi MK; Hassanshahi G; Yousefi H
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):398-401. PubMed ID: 19414941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy.
    Tseng TC; Liu CJ; Hsieh SC; Chen PJ; Lai MY; Chen DS; Kao JH
    Dig Liver Dis; 2009 Apr; 41(4):322-3. PubMed ID: 18848814
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of occult hepatitis B virus coinfection on the incidence of fibrosis and hepatocellular carcinoma in chronic hepatitis C.
    Matsuoka S; Nirei K; Tamura A; Nakamura H; Matsumura H; Oshiro S; Arakawa Y; Yamagami H; Tanaka N; Moriyama M
    Intervirology; 2008; 51(5):352-61. PubMed ID: 19127078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C.
    Fang Y; Teng X; Xu WZ; Li D; Zhao HW; Fu LJ; Zhang FM; Gu HX
    J Med Virol; 2009 May; 81(5):826-35. PubMed ID: 19319940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
    J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of hepatocyte expression of hepatitis B viral antigens with histological activity and viral titer in chronic hepatitis B virus infection: an immunohistochemical study.
    Ramakrishna B; Mukhopadhya A; Kurian G
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1734-8. PubMed ID: 18713304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What can be revealed by extending the sensitivity of HBsAg detection to below the present limit?
    Togashi H; Hashimoto C; Yokozawa J; Suzuki A; Sugahara K; Saito T; Yamaguchi I; Badawi H; Kainuma N; Aoyama M; Ohya H; Akatsuka T; Tanaka Y; Mizokami M; Kawata S
    J Hepatol; 2008 Jul; 49(1):17-24. PubMed ID: 18479773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfusions of red blood cells from an occult hepatitis B virus carrier without apparent signs of transfusion-transmitted hepatitis B infection.
    Furuta RA; Kondo Y; Saito T; Tomita M; Oka K; Kishimoto Y; Tani Y; Shibata T
    Transfus Med; 2008 Dec; 18(6):379-81. PubMed ID: 19140823
    [No Abstract]   [Full Text] [Related]  

  • 37. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan.
    Mu SC; Lin YM; Jow GM; Chen BF
    J Hepatol; 2009 Feb; 50(2):264-72. PubMed ID: 19070923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
    Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A
    Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New markers of hepatitis B virus. Diagnostic and prognostic value].
    Maupas P; Coursaget P; Goudeau A; Drucker J; Grenier B
    Nouv Presse Med; 1977 Jan; 6(1):32-40. PubMed ID: 834546
    [No Abstract]   [Full Text] [Related]  

  • 40. [Challenges regarding the treatment of viral hepatitis B].
    Zhang DF
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):481-2. PubMed ID: 16042876
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.